Long-term results of alcohol ablation of the septal branch of coronary artery in hypertrophic obstructive cardiomyopathy

Kardiologia Polska

Volumn 53, Issue 10, 2000, Pages 273-279

  Kornacewicz Jach, Z ^a   Wojtarowicz, A ^a   Kazmierczak, J ^a   Gil, R ^a   Szamlewski, P ^a   Goos, H ^a   Goracy, J ^a   Plonska, E ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Hypertrophic obstructive cardiomyopathy; Transcoronary alcohol septal ablation

Indexed keywords

ACEBUTOLOL; ALCOHOL; DILTIAZEM; PERINDOPRIL; PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXERCISE; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MITRAL VALVE; MITRAL VALVE REGURGITATION; POST EXTRA SYSTOLIC POTENTIATION; PROGNOSIS; SYNCOPE; THORAX PAIN; TREATMENT OUTCOME; VALSALVA MANEUVER;

EID: 0033735426     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Clinical picture and therapy of hypertrophic cardiomyopathy
2. Hypertrophic cardiomyopathy: Clinical spectrum and treatment
3. Heart reduction surgery: An analysis of the impact on cardiac function
4. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
5. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardomyopathy
6. Electromechanical left ventricular behaviour following nonsurgical septal reduction in patients with hypertrophic cardiomyopathy
7. Effect of dual-chamber pacing o systolic and diastolic function in patients with hypertrophic cardiomyopathy: Acute doppler echocardiographic and catheterization hemodynamic study
8. Comparison of dual-chamber pacing versus myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise endpoints
9. Induced septal infarction: A new therapeutic strategy for hypertrophic obstructive cardiomyopathy
10. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
11. Technique and results of percutaneous transluminal septal myocardial ablation (PTSMA). Impact of contrast echo on PTSMA
12. Remodeling after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy results in ongoing outflow tract gradient reduction
13. Wczesne wyniki alkoholowej ablacji tetnicy septalnej w kardiomiopatii przerostowej z zawezeniem drogi odplywu
14. Alkoholowa ablacja tetnicy septalnej. Wczesna ocena echokardiograficzna
15. Nonsurgical septal reduction of hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
16. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH)
17. Alcoholization of the interventricular septum (Sigwart procedure) for treatment of hypertrophic cardiomyopathy
18. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy
19. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
20. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography
21. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
22. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment
23. Non-surgical reduction therapy for hypertrophic obstructive cardiomyopathy: One year follow-up